Engineered chemokines, resistant to cancer-mediated post-transcriptional modifications, as drugs to improve cancer immunotherapy
O
Ofer Mandelboim
(The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel Canada (IMRIC), Hebrew University-Hadassah Medical School)
A
Angel Porgador
(The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev)
Article Details
Volume / Issue
Vol. 122, Issue 21
Published
May 27, 2025
ISSN
0027-8424
Publisher
National Academy of Sciences
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
ISSN: 0027-8424 Life Sciences
Authors (2)
O
Ofer Mandelboim
The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel Canada (IMRIC), Hebrew University-Hadassah Medical School
A
Angel Porgador
The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev
Related Articles from this Journal
Nature’s antivenom: Combinations of conserved rattlesnake serum metalloproteinase inhibitors block the lethal action of viper venoms
Sean B. Carroll, Fiona P. Ukken et al.
Aug 2026
10.1073/pnas.2612168123
Accelerating <i>Campylobacter</i> zoonosis in the Anthropocene
Oakem J. Kyne, Bridget S. Penman et al.
Aug 2026
10.1073/pnas.2609969123
Global threat exposure of islands in a changing world
Clara Marino, Martin Philippe-Lesaffre et al.
Aug 2026
10.1073/pnas.2534106123
A wearable patch for continuous levodopa monitoring in sweat: Towards exertion and power-free pharmacodynamic assessment in Parkinson’s disease
Tamoghna Saha, Muhammad Inam Khan et al.
Aug 2026
10.1073/pnas.2610453123
Energy prioritization and neurometabolic scaling in a social insect brain
Zach N. Coto, Dajia Ye et al.
Aug 2026
10.1073/pnas.2605431123